Mitochondrial DNA mutation pathogenicity score and neurocognitive performance in persons with HIV
Karen E. Volpe(Vanderbilt University Medical Center), Todd Hulgan(Vanderbilt University Medical Center), Joanna L. Elson(Wellcome Centre for Mitochondrial Research), Asha Kallianpur(Cleveland Clinic Lerner College of Medicine), Scott Letendre, Jannetta S. Steyn(Newcastle University), Robert K. Heaton(University of California San Diego), Tebeb Gebretsadik(Children's Center), Ronald J. Ellis(University of California, San Diego), David C. Samuels(Vanderbilt University)
Cited by 0
Related Papers
New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis
|BMC Medicine|2020|458
Mitochondrial DNA G10398A Polymorphism and Invasive Breast Cancer in African-American Women
|Cancer Research|2005|259
Correction: Corrigendum: Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART
|Scientific Reports|2016|247
Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program
|Clinical Infectious Diseases|2012|208